RS49838B - Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje - Google Patents

Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje

Info

Publication number
RS49838B
RS49838B YUP-345/00A YU34500A RS49838B RS 49838 B RS49838 B RS 49838B YU 34500 A YU34500 A YU 34500A RS 49838 B RS49838 B RS 49838B
Authority
RS
Serbia
Prior art keywords
hydrogenated castor
castor oil
acting injectable
formulations containing
long acting
Prior art date
Application number
YUP-345/00A
Other languages
English (en)
Inventor
James B. WILLIAMS
Rey T. CHERN
Original Assignee
Merck& Co. Inc.,
Merial Llc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26313620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49838(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9809792.6A external-priority patent/GB9809792D0/en
Application filed by Merck& Co. Inc.,, Merial Llc., filed Critical Merck& Co. Inc.,
Publication of YU34500A publication Critical patent/YU34500A/sh
Publication of RS49838B publication Critical patent/RS49838B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Injektabilna formulacija dugog dejstva,naznačena time što uključuje: (a) terapijski agens odabran iz grupe koja se sastoji od insekticida, akaricida, paraziticida, stimulatora rasta i nesteroidnih antiinflamatornih lekova rastvorljivih u uljima, (b) hidrogenisanog ricinusovog ulja, i (c) hidrofobnog nosača, koji uključuje: (i) triacetin, benzil-benzoat ili etil-oleat ili njihovu kombinaciju; i (ii) acilovane monogliceride, propil-dikaprilate/dikaprate, trigliceride kaprilne/kaprinske kiseline ili njihovu kombinaciju.
YUP-345/00A 1997-12-03 1998-09-14 Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje RS49838B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6737497P 1997-12-03 1997-12-03
GBGB9809792.6A GB9809792D0 (en) 1998-05-07 1998-05-07 Long acting injectable formulations containing hydrogenated castor oil

Publications (2)

Publication Number Publication Date
YU34500A YU34500A (sh) 2002-11-15
RS49838B true RS49838B (sr) 2008-08-07

Family

ID=26313620

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-345/00A RS49838B (sr) 1997-12-03 1998-09-14 Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje

Country Status (28)

Country Link
EP (1) EP1035835B1 (sr)
JP (1) JP3925900B2 (sr)
KR (1) KR100499438B1 (sr)
CN (1) CN1205921C (sr)
AR (1) AR017779A1 (sr)
AT (1) ATE249206T1 (sr)
AU (1) AU749006B2 (sr)
BG (1) BG65147B1 (sr)
BR (1) BR9815352A (sr)
CA (1) CA2312898C (sr)
CO (1) CO4970836A1 (sr)
DE (1) DE69818093T2 (sr)
DK (1) DK1035835T3 (sr)
EA (1) EA002497B1 (sr)
ES (1) ES2205550T3 (sr)
HK (1) HK1032917A1 (sr)
HR (1) HRP20000366B1 (sr)
HU (1) HU228617B1 (sr)
IL (1) IL136313A (sr)
ME (1) ME00855B (sr)
NO (1) NO329469B1 (sr)
NZ (1) NZ504783A (sr)
PL (1) PL192651B1 (sr)
PT (1) PT1035835E (sr)
RS (1) RS49838B (sr)
SK (1) SK284522B6 (sr)
TW (1) TW550088B (sr)
WO (1) WO1999027906A1 (sr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538031B1 (en) 1999-11-25 2003-03-25 Novartis Animal Health Us, Inc. Method of controlling sea lice infestation in fish
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
JP4502641B2 (ja) * 2002-01-24 2010-07-14 ティルタン ファーマ リミテッド 抗癌組み合わせおよびその使用方法
CN1275589C (zh) * 2002-05-31 2006-09-20 王玉万 含抗寄生虫药物的缓释注射剂
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
WO2004045581A1 (fr) * 2002-11-18 2004-06-03 Yuwan Wang Injection d'une suspension d'un antiparasite veterinaire
WO2004047803A1 (fr) * 2002-11-27 2004-06-10 Eco Animal Health Ltd Injection de medicament pour animaux renfermant du closantel ou du sodium de closantel
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
TW200505425A (en) * 2003-05-29 2005-02-16 Schering Plough Ltd Compositions and method for treating infection in cattle and swine
CN1293921C (zh) * 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2005084688A1 (fr) * 2004-03-04 2005-09-15 Yuwan Wang Poudre injectable contenant un vermifuge
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
DE102006043444A1 (de) * 2006-09-15 2008-03-27 Bayer Cropscience Ag Suspensionskonzentrate auf Ölbasis
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
GB0804619D0 (en) * 2008-03-12 2008-04-16 Norbrook Lab Ltd A topical ectoparasiticide composition
KR101660068B1 (ko) * 2008-11-19 2016-09-26 메리얼 인코포레이티드 기생충 감염 치료를 위한 1-아릴피라졸 단독 또는 포름아미딘과의 조합을 포함하는 조성물
WO2011046853A1 (en) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2877027A1 (en) * 2012-07-27 2015-06-03 Novartis Tiergesundheit AG New treatment of fish with a nanosus pens ion of lufenuron or hexaflumuron
MX363173B (es) * 2012-12-12 2019-03-12 Zoetis Services Llc Composiciones inyectables de fenilpirazol.
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
CN104337761B (zh) * 2013-08-07 2019-03-26 江苏豪森药业集团有限公司 氟维司群药物组合物
KR101817028B1 (ko) * 2013-12-16 2018-01-09 조에티스 서비시즈 엘엘씨 지속성 케토프로펜 조성물
CN103721266A (zh) * 2014-01-06 2014-04-16 王玉万 含阿维菌素类药物/氢化蓖麻油的原位胶凝注射剂
US10286003B2 (en) 2015-06-10 2019-05-14 Piedmont Animal Health, Llc Injectable antibiotic formulations and use thereof
WO2020223959A1 (en) * 2019-05-09 2020-11-12 The Procter & Gamble Company Stable anti-mite liquid laundry detergent composition comprising benzyl benzoate
CN110585124A (zh) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 一种含有雌三醇或其衍生物的油性注射剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1060632A (en) * 1962-09-11 1967-03-08 Olin Mathieson Steroid compositions
DE2548413A1 (de) * 1975-10-27 1977-04-28 Schering Ag Depotpraeparate in oeliger ungesaettigter loesung zur intramuskulaeren injektion
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0237482A1 (de) * 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
ATE89560T1 (de) * 1986-03-25 1993-06-15 Sankyo Co Makrolid-derivate, ihre herstellung und ihre verwendung.
ES2039258T3 (es) * 1986-07-02 1993-09-16 Ciba-Geigy Ag Pesticidas.
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) * 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (de) * 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ES2131515T3 (es) * 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
EP0873127B1 (en) * 1995-09-25 2006-11-15 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl

Also Published As

Publication number Publication date
SK8292000A3 (en) 2000-11-07
JP3925900B2 (ja) 2007-06-06
PT1035835E (pt) 2003-12-31
NO329469B1 (no) 2010-10-25
ME00855B (me) 2008-08-07
IL136313A (en) 2005-08-31
WO1999027906A1 (en) 1999-06-10
HRP20000366A2 (en) 2001-06-30
NZ504783A (en) 2002-12-20
AR017779A1 (es) 2001-10-24
IL136313A0 (en) 2001-05-20
EP1035835B1 (en) 2003-09-10
HK1032917A1 (en) 2001-08-10
TW550088B (en) 2003-09-01
EA200000604A1 (ru) 2000-12-25
HUP0100606A3 (en) 2002-11-28
BG104560A (en) 2001-04-30
CN1205921C (zh) 2005-06-15
PL192651B1 (pl) 2006-11-30
SK284522B6 (sk) 2005-05-05
DE69818093D1 (de) 2003-10-16
JP2001524510A (ja) 2001-12-04
ES2205550T3 (es) 2004-05-01
NO20002830L (no) 2000-08-03
ATE249206T1 (de) 2003-09-15
KR20010032760A (ko) 2001-04-25
CO4970836A1 (es) 2000-11-07
EA002497B1 (ru) 2002-06-27
CN1283990A (zh) 2001-02-14
CA2312898C (en) 2004-05-11
KR100499438B1 (ko) 2005-07-07
NO20002830D0 (no) 2000-06-02
YU34500A (sh) 2002-11-15
AU749006B2 (en) 2002-06-13
HU228617B1 (en) 2013-04-29
HUP0100606A2 (hu) 2001-06-28
PL341542A1 (en) 2001-04-23
DK1035835T3 (da) 2003-12-08
EP1035835A1 (en) 2000-09-20
AU9385898A (en) 1999-06-16
CA2312898A1 (en) 1999-06-10
DE69818093T2 (de) 2004-06-09
HRP20000366B1 (en) 2009-08-31
BG65147B1 (bg) 2007-04-30
BR9815352A (pt) 2000-10-17

Similar Documents

Publication Publication Date Title
RS49838B (sr) Injektibilne formulacije dugog dejstva koje sadrže hidrogenisano ricinusovo ulje
DE3686483T2 (de) Arzneimittel.
NO953278L (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
DE69328492D1 (de) Fettsäure-derivate und diese enthaltende pharmazeutische präparationen
DE69323442T2 (de) Flüssige pharmazeutische Formulierung mit verlängerter Wirkstoffabgabe
ES2171933T3 (es) Derivados de androsteno.
DE59309714D1 (de) Pharmazeutische und/oder kosmetische Zubereitung
ES2125342T3 (es) Esteres y combinaciones de un nitrato organico y de un salicilato.
NO863935D0 (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
ES2034926T1 (es) Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria.
AR002982A1 (es) Benzonitrilos y benzofluoruros, un procedimiento para prepararlos, su empleo para preparar médicamentos, un médicamento hecho a base de estos compuestos, las preparaciónes farmacéuticas que los contienen y un procedimiento para obtener estas preparaciónes farmacéuticas.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
SV1998000119A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa. ref. lea 32671-sv
SE8404065D0 (sv) Novel biologically active compounds
KR910018020A (ko) 프라바스타틴과 피브르산 유도체의 혼합제. 및 이 혼합제를 사용한 이상지혈증 치료 방법
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
DE69106892D1 (de) Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.
SE9804192D0 (sv) New formulation
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
CA2140781A1 (en) Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
ES1032126Y (es) Juego esterilizable para la autoinyeccion de drogas.
IT7821130A0 (it) Insetticidi contenenti come ingrediente attivo un estere dell'acido isovalerico.
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.
IT7921320A0 (it) Esteri della salicilammide conattivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche.